EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 46.70
-0.40 (-0.85%)
At close: Jun 25, 2026
EirGenix Market Cap
EirGenix has a market cap or net worth of 14.14 billion as of June 25, 2026. Its market cap has decreased by -25.62% in one year.
Market Cap
14.14B
Enterprise Value
12.41B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.70
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 14.14B, an increase of 210.35%. That is a compound annual growth rate of 12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 14.14B | -24.24% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.68B |
| Sunmax Biotechnology | 20.51B |
| TaiMed Biologics | 17.62B |
| Lumosa Therapeutics | 17.17B |
| Ever Supreme Bio Technology | 15.52B |
| Medigen Vaccine Biologics | 15.16B |
| Tanvex BioPharma | 11.99B |
| Polaris Group | 11.65B |